Alterations in kidney tissue following zinc supplementation to STZ-induced diabetic rats

Journal of Trace Elements in Medicine and Biology

Volumn 27, Issue 1, 2013, Pages 52-57

  Karatug, Ayse ^a   Kaptan, Engin ^a   Bolkent, Sehnaz ^a   Mutlu, Ozgur ^a   Yanardag, Refiye ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Diabetes; Oxidative stress; Rat; Renal damage; Zinc

Indexed keywords

BUFFER; CITRIC ACID; CREATININE; GLUTATHIONE; LIPID; STREPTOZOCIN; UREA; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; FEMALE; GLYCOSYLATION; HISTOCHEMISTRY; KIDNEY PARENCHYMA; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; FEMALE; KIDNEY; RATS; RATS, INBRED STRAINS; STREPTOZOCIN; ZINC SULFATE;

ANIMALIA; RATTUS;

EID: 84872425476     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2012.07.006     Document Type: Article

References (48)

1. Bolkent S., Bolkent S., Yanardag R., Mutlu O., Yildirim S. Alterations in Somatostatin cells and biochemical parameters following zinc supplementation in gastrointestinal tissue of streptozotocin-induced diabetic rats. Acta Histochem Cytochem 2006, 39(1):9-15.
2. Jansen J., Karges W., Rink L. Zinc and diabetes - clinical links and molecular mechanisms. J Nutr Biochem 2009, 20(6):399-417.
3. Hönscheid A., Rink L., Haase H. T-lymphocytes: a target for stimulatory and inhibitory effects of zinc ions. Endocr Metab Immune Disord Drug Targets 2009, 9(2):132-144.
4. Devirgiliis C., Zalewski P.D., Perozzi G., Murgia C. Zinc fluxes and zinc transporter genes in chronic diseases. Mutat Res 2007, 622(1-2):84-93.
5. Chausmer A.B. Zinc, insulin and diabetes. J Am Coll Nutr 1998, 17(2):109-115.
6. Gabius H.J. Animal lectins. Eur J Biochem 1997, 243:543-576.
7. Yabuki A., Suzuki S., Matsumoto M., Nishinakagawa H. Lectin-histochemical and -cytochemical study of periodic acid Schiff-positive lysosome granules as a histological feature of the female mouse kidney. Histol Histopathol 2002, 17(4):1017-1024.
8. Faraggiana T., Malchiodi F., Prado A., Churg J. Lectin-peroxidase conjugate reactivity in normal human kidney. J Histochem Cytochem 1982, 30(5):451-458.
9. Liangos O., Perianayagam M.C., Vaidya V.S., Han W.K., Wald R., Tighiouart H., et al. Urinary N-acetyl-beta-(d)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18(3):904-912.
10. Wong S.E., Winbanks C.E., Samuel C.S., Hewitson T.D. Lectin histochemistry for light and electron microscopy. Methods Mol Biol 2010, 611:103-114.
11. Bray T.M., Bettger W.J. The physiological role of zinc as an antioxidant. Free Radic Biol Med 1990, 8(3):281-291.
12. Prasad A.S. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 2009, 12(6):646-652.
13. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283(2-3):65-87.
14. Relander A., Raiha C.E. Differences between the enzymatic and o-toluidine methods of blood glucose determination. Scand J Clin Lab Invest 1963, 15:221-224.
15. Barker S.B. The direct colorimetric determination of urea in blood and urine. J Biol Chem 1944, 152:453-463.
16. Bonsnes R.W., Taussky H.H. On the colorimetric determination of creatinine by the Jaffe Reaction. J Biol Chem 1945, 158:581-591.
17. Beutler E. Glutathione in red blood cell metabolism: a manual of biochemical method. 1975, Grune and Stratton, New York, p. 112-4. 2nd ed.
18. Ledwozyw A., Michalak J., Stepien A., Kadziolka A. The relationship plasma triglycerides, cholesterol, total lipids, and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 1986, 155:275-284.
19. Parker K.M., England J.D., Casto J.D., Hessel R., Goldstein P.E. Improved colorometric assay for glycosylated hemoglobin. Clin Chem 1981, 27:669-672.
20. Lowry O.H., Rosebrough W.I., Farr A.L., Randal R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
21. Bolkent S., Yanardag R., Bolkent S., Mutlu O., Yildirim S., Kangawa K., et al. The effect of zinc supplementation on ghrelin-immunoreactive cells and lipid parameters in gastrointestinal tissue of streptozotocin-induced diabetic rats. Mol Cell Biochem 2006, 286:77-85.
22. Failla M.L., Kiser R.A. Altered tissue content and cytosol distribution of trace metals in experimental diabetes. J Nutr 1981, 111(11):1900-1909.
23. Johnson W.T., Evans G.W. Effects of the interrelationship between dietary protein and minerals on tissue content of trace metals in streptozotocin-diabetic rats. J Nutr 1984, 114(1):180-190.
24. Feng W., Qian Q., Ding W., Chai Z. Tissue contents and subcellular distribution of chromium and other trace metals in experimental diabetic rats after intravenous injection of Cr 50-enriched stable isotopic tracer solution. Metabolism 2001, 50(10):1168-1174.
25. Tang Y., Yang Q., Lu J., Zhang X., Suen D., Tan Y., et al. Zinc supplementation partially prevents renal pathological changes in diabetic rats. J Nutr Biochem 2010, 21(3):237-246.
26. Faure P., Roussel A., Coudray C., Richard M.J., Halimi S., Favier A. Zinc and insulin sensitivity. Biol Trace Elem Res 1992, 32:305-310.
27. Basturk T., Altuntaş Y., Kurklu A., Aydin L., Eren N., Unsal A., et al. glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination. Ren Fail 2006, 28(2):125-128.
28. Trof R.J., Di Maggio F., Leemreis J., Groeneveld A.B. Biomarkers of acute renal injury and renal failure. Shock 2006, 26:245-253.
29. Waikar S.S., Bonventre J.V. Biomarkers for the diagnosis of acute kidney injury. Nephron Clin Pract 2008, 109:192-197.
30. Torres C.R., Hart G.W. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes, evidence for O-linked GlcNAc. J Biol Chem 1984, 259(5):3308-3317.
31. Mark B.L., Mahuran D.J., Cherney M.M., Zhao D., Spencer Knapp S., James M.N.G. Crystal structure of Human b-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease. J Mol Biol 2003, 327:1093-1109.
32. Adachi Y., Yoshikawa Y., Sakurai H. Antidiabetic zinc(II)-N-acetyl-l-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activities. Biofactors 2007, 29(4):213-223.
33. Mohamadin A.M., Elberry A.A., Abdel Gawad H.S., Morsy G.M., Al-Abbasi F.A. Protective effects of simvastatin, a lipid lowering agent, against oxidative damage in experimental diabetic rats. J Lipids 2011, 2011:167958.
34. Mega C., Teixeira de Lemos E., Vala H., Fernandes R., Oliveira J., Mascarenhas-Melo F., et al. Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat). Exp Diabetes Res 2011, 2011:162092.
35. Tuzcu M., Sahin N., Dogukan A., Aslan A., Gencoglu H., Ilhan N., et al. Protective role of zinc picolinate on cisplatin-induced nephrotoxicity in rats. J Ren Nutr 2010, 20(6):398-407.
36. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Curr Med Chem 2005, 12(10):1161-1208.
37. Wallach S. Clinical and biochemical aspects of chromium deficiency. J Am Coll Nutr 1985, 4(1):107-120.
38. Dogukan A., Sahin N., Tuzcu M., Juturu V., Orhan C., Onderci M., et al. The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats. Biol Trace Elem Res 2009, 131(2):124-132.
39. Kaneto H., Matsuoka T.A., Nakatani Y., Kawamori D., Matsuhisa M., Yamasaki Y. Oxidative stress and the JNK pathway in diabetes. Curr Diabetes Rev 2005, 1(1):65-72.
40. Raza H., Prabu S.K., Robin M.A., Avadhani N.G. Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes 2004, 53(1):185-194.
41. Berryman A.M., Maritim A.C., Sanders R.A., Watkins J.B. 3RD. Influence of treatment of diabetic rats with combinations of pycnogenol, beta-carotene, and alpha-lipoic acid on parameters of oxidative stress. J Biochem Mol Toxicol 2004, 18(6):345-352.
42. Zhang F., Xu Z., Gao J., Xu B., Deng Y. In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. Environ Toxicol Pharmacol 2008, 26:232-236.
43. Nicotera P., Orrenius S. Role of thiols in protection against biological reactive intermediates. Adv Exp Med Biol 1986, 197:41-51.
44. Scibior A., Zaporowska H. Effects of vanadium(V) and/or chromium(III) on l-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney. J Toxicol Environ Health A 2007, 70(8):696-704.
45. Yu R.A., Xia T., Wang A.G., Chen X.M. Effects of selenium and zinc on renal oxidative stress and apoptosis induced by fluoride in rats. Biomed Environ Sci 2006, 19(6):439-444.
46. Messaoudi I., El Heni J., Hammouda F., Saïd K., Kerkeni A. Protective effects of selenium, zinc, or their combination on cadmium-induced oxidative stress in rat kidney. Biol Trace Elem Res 2009, 130(2):152-161.
47. Vlassara H., Brownlee M., Cerami A. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem 1986, 32(10):B37-B41.
48. Kaneto H., Kajimoto Y., Miyagawa J., Matsuoka T., Fujitani Y., Umayahara Y., et al. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 1999, 48(12):2398-2406.